$ Value
$0
Shares
4,568
Price
$0
Filed
Feb 13
Insider
Name
Szyman Catherine M.
Title
CEO
CIK
0001438538
Roles
Transaction Details
Transaction Date
2026-02-12
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,573
Footnotes
These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain performance restricted stock units. | Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU. | As previously reported, the reporting person was granted 33,424 RSUs on February 12, 2025 and will vest ratably over three years. One-third of the RSUs vested on February 12, 2026, and the remaining RSUs will vest in two equal installments on the second and third anniversaries of the grant date.
Filing Info
Szyman Catherine M.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-12 | MASI | M | $1.5M |
| 2026-02-12 | MASI | F | $0 |
| 2026-02-12 | MASI | M | $0 |
Other Insiders at MASI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sampath Anand
EVP, Ops & Clinical Research
|
— | $2.6M | 2026-01-28 |
|
Szyman Catherine M.
CEO
|
— | — | 2026-02-12 |
|
Young Micah W
EVP & Chief Financial Officer
|
— | — | 2026-02-26 |